| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060100139 Pharmaceutical used for treating HIV infection, the composition and uses thereof |
| 05/11/2006 | US20060100138 Implantable collagen compositions |
| 05/11/2006 | US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 05/11/2006 | US20060100135 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060100133 High beta-conglycinin products and their use |
| 05/11/2006 | US20060099709 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 05/11/2006 | US20060099708 Methods for diagnosis and treatment of MDK1 signal transduction disorders |
| 05/11/2006 | US20060099701 Activators of cyclin-dependent kinases |
| 05/11/2006 | US20060099689 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 05/11/2006 | US20060099687 14926 Receptor, a novel G-protein coupled receptor |
| 05/11/2006 | US20060099686 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 05/11/2006 | US20060099685 Recombinant expression of factor VIII in human cells |
| 05/11/2006 | US20060099684 Polypeptide of given sequence; inhibiting endothelial cell proliferation; restenosis, cancer, eye disorders |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099680 Yeast transformant into which genes associated with synthesis system of O-fucosylated protein are introduced |
| 05/11/2006 | US20060099678 Method of inducing homologous recombination of somatic cell |
| 05/11/2006 | US20060099676 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 05/11/2006 | US20060099674 Chromatographic purification of recombinant human erythropoietin |
| 05/11/2006 | US20060099673 Novel recombinant gene expression method by stop codon suppression |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099670 Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms and the use of the same |
| 05/11/2006 | US20060099659 Method to detect IgE |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099655 Cloning of a human cytoplasmic polyadenylation element binding protein (hCPEB) with sequence-specific RNA binding activity; examining reproductive potential of a oocyte; gene expression |
| 05/11/2006 | US20060099644 Standard for measurement composed of an oxidized LDL/ beta 2-glycoprotein I complex that is not dissociated in the presence of 100 U/ml heparin nor in the presence of 10 mM MgCl2; disease diagnosis |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099639 Prolactin receptor gene as a genetic marker for increased litter size in animals |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099633 Human FcgammaRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof |
| 05/11/2006 | US20060099630 NES-1 polypeptides, DNA, and related molecules and methods |
| 05/11/2006 | US20060099622 Of given amino acid sequence; bind to antibodies; detecting integrin; diagnosing and treating disorders |
| 05/11/2006 | US20060099600 Novel acetylcholine transporter |
| 05/11/2006 | US20060099595 Culturing an Huh-7.5 cell line (ATCC accession number PTA-8561) that also has a genomic or subgenomic HCV RNA capable of replication, curing with an antiviral agent, and identifying sublines that are permissive for HCV replication. |
| 05/11/2006 | US20060099594 Method of predicting genetic risk for hypertension |
| 05/11/2006 | US20060099580 Methyl-cpg binding domain protein 2 homologs |
| 05/11/2006 | US20060099575 67 human secreted proteins |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099325 Vegetable protein preparations and use thereof |
| 05/11/2006 | US20060099301 Modified lupin proteins for preparation of water dispersible product forms of fat soluble compounds |
| 05/11/2006 | US20060099275 Cell permeable peptides; inhibit NF-kB activation; inhibit anti-apoptotic processes in cancer cells to promote tumor cell death |
| 05/11/2006 | US20060099268 Photochemically crosslinked collagen scaffolds and methods for their preparation |
| 05/11/2006 | US20060099264 biodegradable; biocompatible; colloids |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099220 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099214 Cancer-linked gene as target for chemotherapy |
| 05/11/2006 | US20060099210 for screening for modulators for treating mental disorders such as bipolar disorder, schizophrenia and depression; polypeptides; polynucleotides; vectors; host cells |
| 05/11/2006 | US20060099202 Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor response |
| 05/11/2006 | US20060099195 Tumor cells with increased immunogenicity and uses therfor |
| 05/11/2006 | US20060099188 Tumor-specific promoter |
| 05/11/2006 | US20060099186 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | US20060099184 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 05/11/2006 | US20060099183 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft |
| 05/11/2006 | US20060099178 Novel use of adenoviruses and nucleic acids coding therefor |
| 05/11/2006 | US20060099175 exhibiting IFNG (interferon gamma) receptor binding activity, comprising peptides having replacements in the amino acid sequences, useful in therapy, in particular for the treatment of respiratory system disorders such as idiopathic pulmonary fibrosis |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099171 Mouse glucocorticoid-induced TNF receptor ligand is costimulatory for T cells |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | CA2586389A1 Modified growth hormones |
| 05/11/2006 | CA2585886A1 Pseudotyped baculovirus and its use |
| 05/11/2006 | CA2585672A1 Combination approaches for generating immune responses |
| 05/11/2006 | CA2585482A1 Treatment of short bowel syndrome patients with colon-in-continuity |
| 05/11/2006 | CA2585311A1 Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions |
| 05/11/2006 | CA2584681A1 Pearmease and suicide genes for antitumoral or antiviral treatment |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1655371A1 System for the production of dimeric proteins based on the transport system of hemolysin of escherichia coli |
| 05/10/2006 | EP1655368A1 Vascular endothelial cell growth factor variants and uses thereof |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655308A1 Adducts of soluble ovalbumin with trivalent iron polyalcohol complexes and method to produce them |
| 05/10/2006 | EP1655307A1 Atopic dermatitis inducer |
| 05/10/2006 | EP1655306A1 Protective antigenes and vaccines for the control of multi species tick infestations |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1654545A2 Secreted polypeptide species associated with cardiovascular disorders |
| 05/10/2006 | EP1654379A2 Methods and compositions for enhanced protein expression and purification |
| 05/10/2006 | EP1654378A2 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 05/10/2006 | EP1654370A2 Accelerated vaccination |
| 05/10/2006 | EP1654368A2 Process for the production of fine chemicals |
| 05/10/2006 | EP1654359A2 Synthetic nucleic acids from aquatic species |
| 05/10/2006 | EP1654287A2 Cd20-binding polypeptide compositions |
| 05/10/2006 | EP1654285A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 05/10/2006 | EP1654284A1 Process for preparing an alpha-1-antitrypsin solution |
| 05/10/2006 | EP1654283A1 Improved method of purifying tfpi and tfpi analogs |
| 05/10/2006 | EP1654282A2 Gelatin capsules |
| 05/10/2006 | EP1654281A1 Crystalline tumor necrosis factor receptor 2 polypeptides |
| 05/10/2006 | EP1654280A2 Preparation of somatostatin peptides |
| 05/10/2006 | EP1654279A2 Adipocyte complement related protein zacrp12 |
| 05/10/2006 | EP1654278A2 Compositions and methods for the treatment of immune related diseases |
| 05/10/2006 | EP1654277A2 Apparatus and method for the selective assembly of protein |
| 05/10/2006 | EP1654276A1 Fungus resistant plants and their uses |
| 05/10/2006 | EP1654275A1 Process for preparation of flax protein isolate |
| 05/10/2006 | EP1654274A1 Nematicidal proteins from lepista nuda |